Latest National Heart, Lung, and Blood Institute Stories
PCORI Commits Up To $25 Million to Fund Trials to Reduce Disparities in Hypertension Outcomes WASHINGTON, Dec.
Data Demonstrate Hydroxyurea Therapy Offers Safe, Effective Disease Management CINCINNATI, Nov.
Trial will evaluate if a daily dose of the statin, pitavastatin, can reduce the elevated risk of cardiovascular disease in this patient population MONTGOMERY, Ala., Oct.
NuvOx Pharma has been awarded a Phase I Small Business Innovative Research contract (contract # HHSN268201400045C) for “Development of Molecular Imaging Agents and Methods to Detect High Risk
RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., April 28, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc.
Albert Einstein College of Medicine is One of Four U.S. Field Sites for Landmark Study BRONX, N.Y., Feb. 24, 2014 /PRNewswire-USNewswire/ -- One in every six people in the U.S.
First findings released by National Institutes of Health (NIH) in largest and most comprehensive study ever conducted on Hispanic health. Washington, DC (PRWEB)
Fashion Incubator designers housed at Macy's in the limelight alongside top designers Carolina Herrera, Nicole Miller, Mark Zunino and more NEW YORK, Feb.
A Custom Online Destination Will House Coverage of The Annual Red Dress CollectionSM Fashion Show and Photos of Site Visitors Wearing Their Most Fashionable Red in Support of ‘National Wear
Effective all year, the initiative provides current information and resources on different health topics each month MIAMI, Feb.
- The act of sweetening by admixture of some saccharine substance.